Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

420 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
Zemmrich C, Lüders S, Gansz A, Sturm CD, Fimmers R, Nadal J, Schmieder RE, Schrader J, Bramlage P. Zemmrich C, et al. Among authors: bramlage p. J Clin Hypertens (Greenwich). 2013 Nov;15(11):815-9. doi: 10.1111/jch.12202. Epub 2013 Sep 16. J Clin Hypertens (Greenwich). 2013. PMID: 24102831 Clinical Trial.
Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2).
Bramlage P, Zemmrich C, Gansz A, Sturm CD, Fimmers R, Nadal J, Schmieder RE, Schrader J, Lüders S. Bramlage P, et al. J Clin Hypertens (Greenwich). 2014 Jan;16(1):41-6. doi: 10.1111/jch.12227. Epub 2013 Nov 8. J Clin Hypertens (Greenwich). 2014. PMID: 24410942 Clinical Trial.
420 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page